Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2002Journal of the American Society of Nephrology

Angiotensin II Receptor Antagonists and Angiotensin-Converting Enzyme Inhibitors Lower In Vitro the Formation of Advanced Glycation End Products

View Full Paper
Ask AI
Bookmark
Share

Authors

TMToshio MiyataToho UniversityCSCharles van Ypersele de StrihouCliniques Universitaires Saint-LucYUYasuhiko UedaTokai University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Miyata et al. (2002) studied this question.

synapsesocial.com/papers/6a932c2c333f2b81dc6dc588https://doi.org/10.1097/01.asn.0000032418.67267.f2
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Advanced Glycation and Lipoxidation End Products2000 · 207 citations
  2. 2Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis.1995 · 596 citations
  3. 3Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-Linking1986 · 1,149 citations
  4. 4Plasma levels of pentosidine in diabetic patients1998 · 164 citations
  5. 5The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis.1996 · 287 citations